Kidney cysts occur following inactivation of polycystins in otherwise intact cilia or following complete removal of cilia by inactivation of intraflagellar transport-related proteins. We investigated the mechanisms of cyst formation in these two distinct processes by combining conditional inactivation of polycystins with concomitant ablation of cilia in developing and adult kidney and liver. We found that loss of intact cilia suppressed cyst growth following inactivation of polycystins and that the severity of cystic disease was directly related to the length of time between the initial loss of the polycystin proteins and the subsequent involution of cilia. This cilia-dependent cyst growth was not explained by activation of the MAPK/ERK, mTOR or cAMP pathways and is likely to be distinct from the mechanism of cyst growth following complete loss of cilia. These data establish the existence of a new pathway defined by polycystin-dependent inhibition and cilia-dependent activation that promotes rapid cyst growth.
A r t i c l e s Autosomal dominant polycystic kidney disease (ADPKD) is one of the most common potentially lethal human monogenic diseases, affecting over 12 million people worldwide. ADPKD manifests as fluid-filled cystic dilation of a small subset of kidney tubules. These cysts result in kidney enlargement that progresses over decades and causes kidney failure in 50% of affected individuals by 60 years of age 1 . Primary cilia have been identified as the key organelle in the pathogenesis of ADPKD and related cystic diseases [2] [3] [4] . In lumen-forming epithelia, such as the kidney tubules, primary cilia are solitary microtubulebased non-motile projections on the apical surface. They have an overlying plasma membrane but are devoid of subcellular organelles and protein-synthetic capacity. Specialized translocation machinery, collectively referred to as intraflagellar transport (IFT), is required to traffic component proteins into and out of cilia 5, 6 . Among the many proteins delivered to cilia by IFT are the integral membrane protein products of the genes mutated in ADPKD, polycystin-1 (PC1) and polycystin-2 (PC2) [7] [8] [9] . Loss of either polycystin results in ADPKD. Kidney cysts also arise in mice following the disruption of cilia by targeted inactivation of genes encoding IFT components, such as the heterotrimeric kinesin component Kif3a 10 and the IFT proteins Ift20 (ref. 11) and Ift88 (refs. 7, 12, 13) .
It is generally hypothesized that the primary cilium of kidney epithelial cells acts as a sensory organelle and that PC1 and PC2 form a receptor-channel sensory complex in the cilium. Flow has been proposed as the proximate signal being transduced 14, 15 , although chemosensory inputs have not been excluded 16 . Examination of a diverse array of model systems has implicated a multitude of effector pathways in ciliary and cystic diseases, including planar cell polarity, canonical Wnt, mTOR, cyclic AMP (cAMP), G protein-coupled receptor, CFTR, epidermal growth factor (EGF) receptor, mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/ERK), cellular calcium ion and cell cycle signaling 4, [17] [18] [19] . Nonetheless, the true genetic relationship between polycystins and cilia has not been explored, leaving open the possibility of divergence between the cellular pathway(s) specifically affected by loss of PC1 or PC2 and the pathways affected by loss of structurally intact cilia. In the current study, we combined inactivation of Pkd1 and Pkd2 with loss of Kif3a and Ift20 to show that structurally intact cilia are required to promote rapid cyst growth following loss of PC1 or PC2. The data show the existence of signaling pathways that exhibit cilia-dependent activation and polycystin-and cilia-dependent inhibition and are central to the pathogenesis of ADPKD.
RESULTS

Loss of cilia reduces cyst growth following loss of polycystins
We initially examined the genetic relationship between cyst formation resulting from the inactivation of polycystins, cilia or both. We used the collecting duct-selective Pkhd1-cre allele 20, 21 in combination with the conditional alleles Pkd1 fl (ref. 22) , Pkd2 fl (ref. 21) , Kif3a fl (ref. 10) and Ift20 fl (ref. 11) . Reporter gene studies showed Cre activity in ~100% of collecting duct cells by post-natal day (P) 7 ( Supplementary  Fig. 1 and Supplementary Note) , with complete disappearance of cilia by P11 in Pkhd1-cre; Kif3a fl/− mice and by P18 in Pkhd1-cre; Ift20 fl/− mice ( Supplementary Fig. 2 and Supplementary Note). The delayed disappearance of cilia in mice with Ift20 inactivation resulted from differences in the rate of disappearance of the respective proteins and the dynamics of cilia disassembly following gene inactivation. Pkhd1-cre; Kif3a fl/− and Pkhd1-cre; Ift20 fl/− mice showed only mild cyst formation at P24 ( Fig. 1 ). Pkhd1-cre; Pkd1 fl/fl and Pkhd1-cre; Pkd2 fl/fl mice exhibited severe cystic disease at the same age ( Fig. 1) . Unexpectedly, A r t i c l e s inactivation of Pkd1 or Pkd2 concomitantly with Kif3a or Ift20, respectively, resulted in intermediate polycystic disease severity (Fig. 1) . The reduced severity of the polycystic phenotype in double mutants compared to polycystin single mutants was apparent using aggregate data on the kidney/body weight ratio, the percentage of cystic area expressed as the cystic index and the serum urea nitrogen concentration ( Fig. 1c,d and Supplementary Fig. 3 ). Immunocytochemistry confirmed the presence of cilia in cysts in polycystin single mutants and the absence of cilia in cysts in double mutants ( Fig. 1e,f) .
The beneficial effect of loss of cilia on cyst formation arising from ADPKD-causing gene mutations was independent of the Cre recombinase transgenic line used and was present at earlier time points (Supplementary Figs. 4 and 5). We also considered whether the relatively mild cyst formation in the cilia-only mutants was the result of a suppressive effect from persistent expression of PC1 at cellular sites outside cilia. We tested this hypothesis by either reducing the gene dosage of Pkd1 in Cdh16-cre; Kif3a fl/fl ; Pkd1 fl/+ mice or by increasing Pkd1 dosage using a three-copy Pkd1 F/H -BAC transgene 23 in Cdh16-cre; Kif3a fl/fl ; Pkd1 F/H -BAC mice. Reduced Pkd1 dosage did not result in increased severity of cysts, and increased Pkd1 dosage did not result in reduced cyst formation compared to Cdh16-cre; Kif3a fl/fl mice (Supplementary Fig. 6 ). These findings suggest that the severity of cyst progression following loss of Pkd1 or Pkd2 alone is dependent on the presence of intact cilia but that cyst progression following loss of cilia alone is independent of polycystin function.
Intact cilia devoid of polycystins are required for rapid cyst growth
One implication of the interdependence of polycystins and cilia in cyst formation is that the longer the period during which intact cilia persist after loss of polycystins, the greater the severity of cyst formation. We tested this mechanism directly by varying the interval between polycystin and cilia loss ( Fig. 2) . Kif3a fl/fl mice had a higher initial amount of Kif3a protein compared to Kif3a fl/− mice ( Fig. 2a) , resulting in the delayed disappearance of cilia in Pkhd1-cre; Kif3a fl/fl kidneys (P14) compared to Pkhd1-cre; Kif3a fl/− kidneys (P11; Supplementary  Fig. 2c,d) . We generated age-matched P24 Pkhd1-cre; Kif3a fl/fl mice and compared kidney cyst disease progression with that in the Pkhd1cre; Kif3a fl/− mice (shown in Fig. 1a,c ). Pkhd1-cre; Kif3a fl/fl mice had reduced cystic index compared to Pkhd1-cre; Kif3a fl/− mice, suggesting that the later loss of cilia in the Pkhd1-cre; Kif3a fl/fl cilia-only mutant mice delayed the onset of cyst growth (Fig. 2b,c and Supplementary  Fig. 3 ). Comparison of Pkhd1-cre; Kif3a fl/fl ; Pkd1 fl/fl mice at P24 with the Pkhd1-cre; Kif3a fl/− ; Pkd1 fl/fl mice from Figure 1a,c showed that the same delay in loss of cilia in the cilia and polycystin double mutant had the opposite effect, increasing the severity of cysts (Fig. 2b,c and Supplementary Fig. 3 ). We next tested this mechanism by taking the opposite approach in decreasing the germline dosage of Pkd2. Reduced basal amounts of PC2 ( Fig. 2d) , resulting in earlier disappearance of the protein following Cre-mediated gene inactivation, gave rise to increased cyst severity in Pkhd1-cre; Pkd2 fl/− mice compared to Pkhd1-cre; Pkd2 fl/fl mice ( Fig. 2e,f) . In the setting of invariant timing of cilia loss on the Kif3a fl/fl background, Pkhd1-cre; Kif3a fl/fl ; Pkd2 fl/− mice, with a prolonged interval between PC2 and cilia loss, showed more severe polycystic disease than Pkhd1-cre; Kif3a fl/fl ; Pkd2 fl/fl mice ( Fig. 2e,f) .
We were able to complement the genetic data to show that loss of polycystin protein antecedes the involution of cilia in our models. We selected time points P7, P10 and P15 to evaluate the course of PC2 and cilia loss in the collecting ducts of Pkhd1-cre; Kif3a fl/fl ; Pkd2 fl/fl doublemutant mice ( Fig. 2g-l) . Control mice had intact cilia that expressed PC2 ( Fig. 2g,k) . At P7, double-knockout mice had intact cilia that either did not express PC2 or expressed very little PC2 compared to tubule segments in which Pkhd1-cre was not active (Fig. 2h,i) . At P10, intact cilia remained but were completely devoid of PC2 ( Fig. 2j) . At P15, cilia were no longer present in the double knockouts (Fig. 2l) . The immunofluorescence data showed that cilia without polycystin were present by P7 and persisted through P14, after which point cilia were no longer present. PC1 could not be detected by immunofluorescence, in a manner similar to PC2. PC1 is a lower abundance protein than PC2, and its dosage is rate limiting in cyst formation 23 , so it is reasonable to extrapolate that PC1 disappears from cilia even earlier than PC2. This longer period during which cilia are present without polycystin results in more severe cystic changes (compare Kif3a fl/fl ; Pkd1 fl/fl kidneys in Fig. 2b,c to Kif3a fl/fl ; Pkd2 fl/fl kidneys in Fig. 2e,f) .
The data support the hypothesis that intact cilia elaborate a positive signal for rapid cyst growth that is normally inhibited by polycystin action. The activity of this cyst-promoting signal requires structurally preserved cilia and is maximally active when cilia are devoid of polycystins, as is the case in ADPKD.
Cilia and polycystin double mutants have slowed adult-onset PKD
The course of ADPKD is substantially slower in adult mice following conditional inactivation of polycystins or cilia 13, 24 . We next determined whether cilia ablation was beneficial in more indolent adult forms of polycystic kidney disease using the kidney-selective whole-nephron biallelic Pax8 rtTA ; TetO-cre doxycycline-inducible system 25 (Fig. 3) . We induced mice with oral doxycycline from P28-P42 and determined the pattern of Cre reporter gene activity along the nephron and the timing of cilia loss ( Supplementary Fig. 7 and Supplementary Note). There was minimal cyst formation 8 weeks after the start of doxycycline induction in both Pax8 rtTA ; TetO-cre; Pkd1 fl/fl single-mutant and Pax8 rtTA ; TetO-cre; Kif3a fl/fl ; Pkd1 fl/fl double-mutant kidneys ( Fig. 3a,b) . Nonetheless, Pax8 rtTA ; TetO-cre; Pkd1 fl/fl single-mutant kidneys already showed an increased npg kidney/body weight ratio and an increased cystic index, primarily due to early cortical nephron cyst formation ( Fig. 3a,b ). These differences became profoundly apparent 14 weeks after of the start of doxycycline induction, with Pax8 rtTA ; TetO-cre; Kif3a fl/fl ; Pkd1 fl/fl double-mutant kidneys remaining indistinguishable from those of wild-type mice, whereas Pax8 rtTA ; TetO-cre; Pkd1 fl/fl single-mutant kidneys showed marked cyst progression and significant renal functional impairment ( Fig. 3c,d) . Similar results were obtained with Kif3a and Pkd2 double mutants compared to Pkd2 single mutants (Supplementary Fig. 8) .
We evaluated the temporal relationship between loss of the polycystin and Kif3a proteins in these adult-onset mouse models. Immunoblotting of kidney tissue lysates collected 1, 2 and 3 weeks after the start of doxycycline induction showed that PC2 amounts were already markedly reduced by 1 week, whereas Kif3a amounts required a longer time to show comparable changes in abundance ( Fig. 3e) . Immunofluorescence studies similarly showed that PC2 disappeared from cilia well before cilia disappeared in Kif3a and Pkd2 double-mutant kidney tubules. PC2 was detected in cilia from kidney 
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A r t i c l e s tubule cells in control mice (Fig. 3f) , Pkd2 single-mutant mice ( Fig. 3g) and Kif3a and Pkd2 double-mutant mice ( Fig. 3h) 1 week after the start of doxycycline induction. At 11 d, cilia persisted but were devoid of PC2 in Kif3a and Pkd2 double-mutant mice (Fig. 3h) . Cilia became sparse at 2 weeks and were completely absent 3 weeks after the start of doxycycline induction (Fig. 3h) . Liver cysts are part of the ADPKD phenotype in humans. We used the tamoxifen-inducible UBC-cre ER model 26 to show that cilia ablation also markedly slowed bile ductderived cyst growth and had durable effects on kidney cyst growth in Pkd1 models (Supplementary Figs. 9 and 10 and Supplementary Note). Cyst growth pathways dependent on intact cilia are the fundamental mechanism underlying all kidney and liver cyst formation owing to mutations in Pkd1 and Pkd2, irrespective of tissue, cell type or age at cyst initiation. Polycystic kidney and liver disease can be markedly slowed by inhibiting this cilia-dependent pathway, for example, by ablating cilia.
Higher rates of proliferation with intact cilia devoid of polycystins
Cyst growth manifests with increased proliferation of cells that have lost polycystin expression 22, 23 . We determined whether the beneficial effect of concomitant loss of cilia was the result of a decrease in this proliferative response or another mechanism, such as increased apoptosis of cyst cells. We quantified the rate of nephron segment-specific cyst cell proliferation by determining the proportion of nuclei positive for Ki67 or BrdU (5-bromo-2′-deoxyuridine). Collecting duct cysts marked by lectin Dolichos biflorus agglutinin (DBA) in early-onset Pkhd1-cre models showed ~1% proliferation in Kif3a single mutants when determined by either BrdU incorporation or Ki67 staining ( Fig. 4a-d) . Polycystin single mutants with either Pkd1 or Pkd2 mutation showed ~5% proliferation in collecting duct cyst cells ( Fig. 4a-d) .
The rates of proliferation in the cilia and polycystin double mutants were significantly reduced compared to those in the respective polycystin-only mutants and correlated with relative cyst severity in early-onset Pkhd1-cre allele-based models ( Fig. 4a-d) .
We next examined segment-specific rates of proliferation following inactivation by Pax8 rtTA ; TetO-cre in proximal tubules marked by Lotus tetragonolobus agglutinin (LTA) and in collecting ducts marked by DBA 8 and 14 weeks after of the start of doxycycline induction. Consistent with the slower rates of cyst growth, the absolute rates of proliferation were lower in the adult-inducible model compared to in the early-onset Pkhd1-cre model. Nonetheless, proliferation rates in proximal tubules and collecting ducts were elevated in the Pkd1 single mutant compared to wild-type controls (Fig. 4e-h) . The proliferation rates in both segments seemed higher at 14 weeks than at 8 weeks, suggesting that cyst growth rates might not be constant and that there might be amplification of the proliferative signal with progressive polycystic disease. Proliferation rates in cilia and Pkd1 double mutants were indistinguishable from those in wild-type animals ( Fig. 4e-h) , recapitulating the absence of phenotypic differences between mice with these genotypes (Fig. 3) . Reduced proliferation in cilia and polycystin double mutants was also found in the tamoxifeninducible UBC-cre ER adult-onset model (Supplementary Fig. 10 ). There were no differences in the rates of apoptosis, as determined by terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) in any of these models (data not shown). The severity of polycystic disease was correlated with increased rates of cyst cell proliferation, which are at least in part dependent on the presence of intact cilia.
A newly discovered cilia-dependent cyst-activating mechanism
We next sought to evaluate whether known signaling pathways implicated in the pathogenesis of ADPKD exhibited features of cilia dependence that would make them candidates for the newly discovered, polycystin-inhibited, cilia-dependent proliferative cyst-promoting pathway. To this end, we examined the activity of the MAPK/ERK, mTOR and cAMP pathways [27] [28] [29] . These pathways have shown activity in mice with established cystic disease and have been the targets of both preclinical and clinical therapeutic interventions in humans. We used the adult-onset models with Kif3a, Pkd1 and Pax8 rtTA ; TetO-cre alleles 8 and 14 weeks after the start of doxycycline induction. To determine MAPK/ERK activation, we examined the levels of phosphorylated ERK1 and ERK2 in whole-kidney lysates by semiquantitative immunoblotting (Fig. 5a,b) 22 . There were no differences in the levels of phosphorylated ERK based on genotype at 8 weeks after the start of doxycycline induction (Fig. 5a) . At 14 weeks, Pax8 rtTA ; TetO-cre; Pkd1 fl/fl single mutants showed significantly increased levels of phosphorylated ERK, whereas levels in Pax8 rtTA ; TetO-cre; (e,f) Representative immunoblots and aggregate densitometric quantification of kidney lysates show no change in the levels of phosphorylated S6RP, irrespective of genotype and the extent of cyst formation 8 weeks (n = 5 for each group) (e) and 14 weeks (n = 4 for each group) (f) after the start of Cre induction, suggesting that the mTOR pathway is not activated in these adult models. The asterisk by the immunoblot for S6RP in f indicates a non-specific band. (g-i) In vivo cAMP-dependent phosphorylation of CREB (pCREB) 8 weeks (g) and 14 weeks (h,i) after the start of Cre induction. Shown are representative immunoblots and aggregate densitometric quantification for nuclear and non-nuclear fractions of kidney tissue lysates. The activity of phosphorylated CREB is elevated at 6 weeks (n = 3 for each group) (g) and 12 weeks (n = 4 for each group) (h) only in Pax8 rtTA ; TetO-cre; Pkd1 fl/fl cystic mice. Asterisks by the immunoblots in g,h denote the phosphorylated form of the cAMPdependent transcription factor ATF-1 that is known to cross-react with the antibody to phosphorylated CREB. LaminA/C and calnexin are used to show relative nuclear enrichment and control loading. (i) Immunohistochemistry of phosphorylated CREB (green) 14 weeks after the start of Cre induction shows nuclear staining in the collecting duct (DBA, red) that is markedly increased in Pax8 rtTA ; TetO-cre; Pkd1 fl/fl cystic mice. Phosphorylated CREB is completely absent from the LTA-positive (red) proximal tubule, irrespective of genotype or the degree of cystic transformation. Pax8 rtTA ; TetO-cre; Pkd1 fl/fl cystic mice also show increased levels of phosphorylated CREB in the nuclei of segments that are negative for DBA (lower right). The numbers of animals (n) in each group are indicated below the histogram bars. Multiple-group comparisons were performed using one-way ANOVA followed by Tukey's multiple-comparison test and are presented as mean ± s.e.m., except as indicated above. ***P < 0.001; **P < 0.01; *P < 0.05. Scale bars, 40 µm. double mutants did not differ from those in wildtype mice (Fig. 5b) . Immunohistochemistry in kidneys at 14 weeks showed that phosphorylated ERK was expressed in collecting ducts, irrespective of genotype, suggesting that at least some of the increase in phosphorylated ERK in cystic kidneys was related to increased cell mass of this segment as a result of cyst progression (Fig. 5c) . The cystic Pax8 rtTA ; TetO-cre; Pkd1 fl/fl single mutants also had increased levels of phosphorylated ERK in the thick ascending loop of Henle, and this increase appeared to be a feature of progressive polycystic disease (Fig. 5c, bottom) . Phosphorylated ERK was uniformly absent from proximal tubules in all genotypes, irrespective of the presence of cysts (Fig. 5c) . These results are notable for two reasons. First, the absence of increased levels of phosphorylated ERK at 8 weeks, when early cyst formation and increased proliferation are already apparent in Pax8 rtTA ; TetO-cre; Pkd1 fl/fl single mutants (Figs. 3a,b  and 4e-h) , suggests that the earliest stages of cyst growth following loss of PC1 are not associated with MAPK/ERK pathway activation. Second, the complete absence of any ERK activation, even in late-stage and markedly cystic Pax8 rtTA ; TetO-cre; Pkd1 fl/fl proximal tubules, indicates that MAPK/ERK activation is not a ubiquitous contributor to cyst growth in ADPKD. Taken together, the data make it unlikely that MAPK/ERK-mediated pathways are responsible for the generalized cyst-growth-inducing signal dependent on intact cilia following inactivation of Pkd1.
Abnormal activation of mTOR has been implicated in ADPKD 30, 31 and has been linked to cilia function 15, 32 . mTOR inhibitors were among the first agents tested in large-scale clinical trials in patients with ADPKD 33, 34 . We evaluated mTOR activation by assaying the phosphorylation of a downstream target, S6 ribosomal protein (S6RP), using semiquantitative immunoblotting of kidney lysates. We verified the ability of the antibodies to detect decreased levels of phosphorylated S6RP following downregulation of mTOR in the setting of serum starvation (Fig. 5d) . We found no discernible differences in the levels of phosphorylated S6RP in kidney tissue lysates from wild-type, Pkd1-only, and cilia and Pkd1 double-mutant kidneys at either 8 or 14 weeks following the start of gene inactivation (Fig. 5e,f) . Thus, mTOR activation does not seem to be a major contributor to ADPKD in adult-inducible whole-nephron knockout of Pkd1, irrespective of the presence of intact cilia.
Elevated levels of cAMP are present in animal models of polycystic kidney disease 35, 36 and foster the growth of kidney cysts 37, 38 . cAMP regulates the expression of target genes, in part through protein kinase A-mediated phosphorylation at Ser133 of the transcription factor cAMP-response element-binding protein (CREB). We evaluated cAMP activity in the adult models of ADPKD by semiquantitative immunoblotting in cytoplasmic and nuclear fractions of kidney tissue lysates and by immunohistochemistry ( Fig. 5g-i) . We confirmed the specificity of the antibodies to phosphorylated CREB for immunoblotting and immunocytochemistry by examining cells after activation of cAMP with forskolin ( Supplementary Fig. 11 ). Fractionation of kidney lysates showed that CREB and phosphorylated CREB levels were enriched in nuclear fractions (Fig. 5g,h) . Levels of nuclear phosphorylated CREB that were elevated above baseline were seen at 8 and 14 weeks, but only in Pax8 rtTA ; TetO-cre; Pkd1 fl/fl single mutants. Pax8 rtTA ; TetO-cre; Kif3a fl/fl ; Pkd1 fl/fl double mutants did not show evidence of cAMP activation above the baseline level seen in wildtype animals (Fig. 5g,h) . Immunohistochemical analysis of phosphorylated CREB levels in kidney sections showed increased nuclear expression in cyst-lining cells (Fig. 5i) . As was the case with MAPK/ ERK activation, cAMP activation was confined to distal nephron segments and was completely absent from proximal tubules, regardless of genotype or cyst burden (Fig. 5i) . Because cilia ablation is effective in ameliorating cyst growth in all segments, including the proximal tubule, the absence of cAMP activation in proximal tubule cysts suggests that cAMP is not fundamental to the activity of the cilia-dependent cyst growth pathway following loss of Pkd1. The aggregate genetic data point to a newly discovered cyst-promoting pathway dependent on intact cilia devoid of functional polycystins that may be an ideal therapeutic target for treatment of ADPKD.
DISCUSSION
We define a new and unexpected relationship between the integrity of cilia structure and polycystin function-the existence of a ciliadependent cyst growth-promoting pathway that specifically affects cyst growth dependent on the presence of intact cilia devoid of either PC1 or PC2. The activity of this pathway determines cyst progression following both early and late ADPKD gene inactivation, is equally applicable to polycystic kidney and polycystic liver disease, and is active in cyst growth in all nephron segments. None of the pathways implicated in the pathogenesis of ADPKD so far, except those mediated by PC1 and PC2 themselves, have achieved this degree of universality in determining the disease phenotype. The success of cilia ablation in reducing cyst growth, irrespective of timing or tissue of polycystin gene inactivation, suggests that differences in orthologous gene models of ADPKD, for example, early versus late inactivation, are more differences in degree than in fundamental mechanism. A common therapeutic strategy should be effective in ADPKD, regardless of the timing or tissue of cyst formation.
The mechanism of cystic disease in cilia and polycystin dualinactivation models is a function of the duration of the interval between the early disappearance of polycystins and the subsequent involution of cilia. In polycystin-only mutants, this interval is indefinite. Our studies leave open the possibility that medicinal inhibition of the cilia-dependent pathway could slow cyst growth, even when applied at times well after loss of polycystin. MAPK/ERK, mTOR and cAMP effectors are unlikely to be central to the cilia-dependent signal, largely because their activation is restricted to specific nephron segments and occurs later. That is not to say that these pathways are not indirectly activated in certain cell types or under certain conditions to actively promote cyst growth. Our findings rather suggest that the cilia-dependent pathway is a more proximate and universally applicable target for reducing cyst growth. Whereas cyst growth following loss of polycystins is cilia-dependent, cyst growth following loss of cilia may be polycystin independent. Loss of cilia alone results in relatively slower cyst growth, and neither concomitant reduction in dosage nor overexpression of PC1 seems to have a substantial effect on this process in vivo.
Our earlier studies have shown that polycystin functions are a continuously regulated trait in which decreases in polycystin signaling result in graded increases in tubule luminal diameter, ultimately leading to cysts when polycystin signaling falls below a critical threshold 23 . The current study shows that PC1 or PC2 input inhibits a signal dependent on intact cilia and that complete loss of this inhibition gives rise to cysts. This signal is unlikely to be a primary proliferation effect, as occurs with neoplasia, because cyst growth requires only low-level proliferation and cells retain differentiated properties. Increased proliferation in cysts is detectable when examined specifically in cells in which Cre recombinase is active, but it is below detection as a differential signal when whole-kidney proliferation is evaluated 24 . The proliferation in cysts is an inherent effect of the polycystin-inhibited, cilia-dependent cyst growth signal, as recent studies have shown that exogenous proliferative signals do not promote cyst growth following npg loss of cilia 39 . It is likely that the normal physiological roles of PC1 and PC2 subsume controlled derepression of this cilia-dependent pathway, promoting functional tubule adaptation to either chemical or mechanical signals.
Loss-of-function mutations in components of the cilia-dependent pathway would not result in cysts and would require a cyst suppressor screen to be discovered in model organisms. Given that we were able to discover dominantly inherited gene mutations for isolated human polycystic liver disease that phenocopy ADPKD by acting indirectly on the biogenesis of polycystins 23 , we expect the human phenotype to be sensitive enough to identify other genes in which heterozygous loss-of-function alleles result in ADPKD. The absence of a third causative gene for ADPKD supports the inhibitory roles of polycystins in a pathway whose other components act constitutively. The potential complexities of the relationship between polycystin function and cilia structure are illustrated by the roles of cilia in Hedgehog-dependent tumorigenesis pathways 40, 41 . Hedgehog ligand binds to Patched on cilia, thereby relieving the repression of Smoothened, which enters the cilium and promotes the translocation of transcriptional activators Gli1 and Gli2 from cilia to the nucleus 42 . Removal of cilia inhibits Hedgehog ligand-dependent carcinomas but perturbs the balance between the activating factors and the Gli3 repressor, thereby promoting tumor growth under conditions mimicking downstream activation of Hedgehog signaling 40, 41 . The prevailing view of the cyst-suppressive role of polycystins is that it requires either mechanical or ligandmediated activation to affect calcium-dependent inhibition of cyst growth 14, 16, 43 . The current findings suggest that, in a manner analogous to the role of Patched, polycystins provide tonic, flow-or ligandindependent suppressive signals for a cilia-dependent signal. In this case, flow or ligand may decrease this inhibition in a regulated manner as part of a normal physiological or homeostatic cilia-dependent signal. Complete loss of polycystins results in constitutive activation of the cilia-dependent cyst-promoting signal, just as ligand-independent Hedgehog signaling occurs in Patched (Ptch1) knockouts 44 .
Our studies strongly suggest, although they do not directly prove, that that the components of cilia-dependent cyst signals are present in cilia, in a manner analogous to the components of Hedgehog signaling. The next steps in the molecular definition of this cilia-dependent pathway will require new strategies directed at discovering intracilial signaling complexes whose loss of function suppresses polycystic disease following inactivation of polycystins. Our in vivo studies serve as a proof of principle that the discovery and targeting of the ciliadependent, polycystin-inhibited pathway will be effective in slowing the course of ADPKD. We propose that this newly discovered ciliadependent pathway is the central biological mechanism for polycystin and cilia signaling in ADPKD. Elucidating the components of the pathway will define superior targets for translation into therapies for this disease.
METHODS
Methods and any associated references are available in the online version of the paper.
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